Innovative chemical monolayer films are proposed to reduce evaporation in large-scale algae cultivation ponds, potentially eliminating the need for freshwater supplies and enhancing sustainability.
This solution involves the use of chemical monolayer films to significantly reduce evaporation in large-scale algae cultivation ponds. By decreasing water loss, these films can potentially minimize or even eliminate the need for freshwater inputs, depending on the salinity of the water source and the specific salt tolerance of the algae. This approach offers a sustainable method for enhancing the efficiency of algae production, applicable across various scales and types of microalgae.
The technology is grounded in the extensive research conducted by Professors Greg Martin and Greg Qiao at the University of Melbourne. Their work has demonstrated the feasibility of using chemical monolayers to reduce evaporation from water storage ponds. A patented application technique ensures efficient deployment of the film, which has been validated in lab-scale tests. The films are designed to form a thin, single-molecule layer that effectively reduces water loss without harming the algae.
The current technology readiness level is 4. This indicates that the concept has been proven in a laboratory setting but requires further development and validation in real-world conditions. Future research could include additional lab-scale tests and outdoor performance trials, ideally in collaboration with partners who can provide algae growth facilities and funding.
The University of Melbourne is a comprehensive institution spanning STEM, health and clinical practice, business and law, and the creative and social disciplines. Co‑located hospital and research precincts, together with an inner‑city innovation ecosystem, place companies, startups, and researchers in shared labs, prototyping spaces, and studios. Engineering and technology programs connect with advanced manufacturing facilities, while structured industry projects and placements link partners with talent and translational problem‑solving. Work is supported by competitive funding from the Australian Research Council and the National Health and Medical Research Council, with additional backing from state programs and industry partners; a dedicated technology transfer office manages IP, licensing, and startup formation.